Cleanroom wipes to see improvements

Expect more features that promote ease of use and protect against cross-contamination in that intrepid soldier of drug production, the wipe. Manufacturers are also executing on promises of environmental preservation by developing products that are biodegradable, for example.

Features under development are task-specific, says market researcher Freedonia Group, in a $4,900 report published last month. Manufacturing and healthcare wipes remain the largest segments within the industrial wipes market. Cleanroom and surface-preparation wipes are expected to be leading subsegments.

Freedonia projects the overall U.S. wipes market to grow at a compound rate of 4.3 percent through 2014, to $2.3 billion. The industrial segment CAGR alone is projected at 4.7 percent, to $1 billion--58 billion units.

- here's the Freedonia release

Suggested Articles

South Korea’s Celltrion, which has a massive biologics site in Songdo, has decided it is time to build some operations in China.

WuXi Biologics is taking control of a Bayer plant in Germany and agreed it could serve as a backup facility for supply of hemophilia drug Kovaltry.

A Chinese OTC drugmaker gets the distinction of ringing in the new year as the first company to be slapped with an FDA warning letter.